1. Clinical-Risk Factors that Influence an Optimal Hypomethylating Agents Treatment in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia. (April 2017) Authors: Iastrebner, M.; Lazzarino, C.; Nucifora, E.; Penchasky, D.; Fernandez, I.; Gusmao Moreno, B.G.M.; Rivas, M.M.; Espinosa, D.; Abello Polo, V.; Boada, M.; Enrico, A.; Araujo Schuster, S.; Agra, M.; Sarmiento, M.; Flores, G.; Alfonso, G.; Crisp, R.; Gusmao Moreno, B.; Consortium, I. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Flow Cytometry "Ogata Score" in Latin America. On Behalf of the Grupo Latinoamericano De Mielodisplasia (GLAM). (April 2017) Authors: Grille, S.; Brugnini, A.; Velloso DRP, E.; Cismondi, V.; Jensen, E.; Bacal, N.S.; Solari, L.; Novoa, V.; Boada, M.; Crisp, R.; Rojas S, R.; Fanessi, V.; Gonzalez, J.; Cosentino, R.; Rodriguez, M.; Venegas, B.; Trías, N.; Guevara, R.; Enrico, A.; Lens, D. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Topic: AS02-Epidemiology: TP53 MYELODYSPLASTIC SYNDROMES IN LATIN AMERICA. REAL WORLD DATA FROM LATIN AMERICAN MDS GROUP (GLAM). (May 2023) Authors: Boada, M.; Arbelbide, J.; Basquiera, A.; Velloso, E.; Iastrebner, M.; Catalán, A.; Grille, S. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche: GENE EXPRESSION PROFILE OF HUMAN MESENCHYMAL STROMAL CELLS FROM MYELODYSPLASTIC SYNDROME PATIENTS AND HEALTHY CONTROLS. (May 2023) Authors: Boada, M.; Otatti, C.; Straneo, P.; Spangenberg, L.; Grille, S. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Topic: AS08-Treatment/AS08a-Current treatment options – Higher risk MDS: VENETOCLAX AND AZACYTIDINE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES, A REAL-WORLD EXPERIENCE. LATIN-AMERICAN MDS GROUP – GLAM. (May 2023) Authors: Iastrebner, M.; Crisp, R.; Ovilla, R.; Enrico, A.; De Leon, A. Gomez; Varela, A.; Velloso, E.; Puente, A.; Duarte, F.; Gusmao, B. Moreno; Schusterschitz, S.; Wernicke, P.; Boada, M.; Pereyra, P.; Grille, S. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗